NanoViricides
NNVC
#10543
Rank
โ‚น3.01 B
Marketcap
โ‚น118.27
Share price
-3.13%
Change (1 day)
-3.50%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น41.97. In 2025 the company made an earnings per share (EPS) of -โ‚น60.09 an increase over its 2024 EPS that were of -โ‚น66.77.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-34.87%
2025-โ‚น60.09-10%
2024-โ‚น66.77-5.41%
2023-โ‚น70.585.71%
2022-โ‚น66.77-13.58%
2021-โ‚น77.26-66.11%
2020-โ‚น227.961.7%
2019-โ‚น224.14-10.98%
2018-โ‚น251.80-22.35%
2017-โ‚น324.29-10.53%
2016-โ‚น362.44375%
2015-โ‚น76.30-85.19%
2014-โ‚น515.0542.11%
2013-โ‚น362.4426.67%
2012-โ‚น286.14-6.25%
2011-โ‚น305.2114.28%
2010-โ‚น267.06100%
2009-โ‚น133.53-0%
2008-โ‚น133.53-33.33%
2007-โ‚น200.30-0%
2006-โ‚น200.304445.07%
2005-โ‚น4.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น707.72-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.97-912.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น339.55-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น370.68-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น51.51 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น165.01 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA